Nasal drug administration: potential for targeted central nervous system delivery.
about
Nanotechnology-based drug delivery systems for the treatment of Alzheimer's diseaseEnabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicinesNeuronal death induced by misfolded prion protein is due to NAD+ depletion and can be relieved in vitro and in vivo by NAD+ replenishment.Intranasal Delivery of Recombinant AAV Containing BDNF Fused with HA2TAT: a Potential Promising Therapy Strategy for Major Depressive Disorder.Chronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's diseaseEvolving Drug Delivery Strategies to Overcome the Blood Brain Barrier.Vanadium exposure induces olfactory dysfunction in an animal model of metal neurotoxicitySite-specific opening of the blood-brain barrier.Intranasal LPS-mediated Parkinson's model challenges the pathogenesis of nasal cavity and environmental toxins.From the liver to the brain across the blood-brain barrier.Erythropoietin: still on the neuroprotection roadNano-enabled delivery of diverse payloads across complex biological barriers.Acute and Subchronic Oral Toxicity Evaluation of Aqueous Root Extract of Dicoma anomala Sond. in Wistar Rats.Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.Prediction of antiepileptic drug efficacy: the use of intracerebral microdialysis to monitor biophase concentrations.Chitosan-based hydrogels for nasal drug delivery: from inserts to nanoparticles.Intranasal erythropoietin therapy in nervous system disorders.Intranasal delivery of therapeutic proteins for neurological diseases.Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease.Pharmacokinetics of non-intravenous formulations of fentanyl.Nanotechnology for CNS delivery of bio-therapeutic agents.Granular biodurable nanomaterials: No convincing evidence for systemic toxicity.Manganese exposure induces neuroinflammation by impairing mitochondrial dynamics in astrocytes.Determination of 5-hydroxymethyl-2-furaldehyde of crude and processed Fructus Corni in freely moving rats using in vivo microdialysis sampling and liquid chromatographyIntranasal Delivery of Recombinant NT4-NAP/AAV Exerts Potential Antidepressant Effect.Comparative pharmacokinetics of tetramethylpyrazine phosphate in rat plasma and extracellular fluid of brain after intranasal, intragastric and intravenous administration.Nose-to-brain transport of melatonin from polymer gel suspensions: a microdialysis study in rats.A case report of seizure induced by bupropion nasal insufflation.Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil.A new minimal-stress freely-moving rat model for preclinical studies on intranasal administration of CNS drugs.Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats.Evidence for reduced lymphatic CSF absorption in the H-Tx rat hydrocephalus model.Facile development of nanocomplex-in-nanoparticles for enhanced loading and selective delivery of doxorubicin to brain.Nose-to-brain delivery of tacrine.Plasma concentrations and sedative effects of a dexmedetomidine, midazolam, and butorphanol combination after transnasal administration in healthy rabbits.Intranasal administration of brain-targeted HP-β-CD/chitosan nanoparticles for delivery of scutellarin, a compound with protective effect in cerebral ischaemia.Brain targeted delivery of mucoadhesive thermosensitive nasal gel of selegiline hydrochloride for treatment of Parkinson's disease.Non-systemic delivery of topical brimonidine to the brain: a neuro-ocular tissue distribution study.Temporal gene expression profiles of target-ablated olfactory epithelium in mice with disrupted expression of scavenger receptor A: impact on macrophages.The brain targeting efficiency following nasally applied MPEG-PLA nanoparticles in rats.
P2860
Q26783306-2A4B5BFB-B570-416E-8717-F8412800C72CQ26850868-4AD5B44C-7203-439B-801E-11DEFE9BBAD1Q27303843-294D552E-2377-41B7-BE8E-8C947F34FC51Q27335060-1FEC8A06-DC6A-4CF0-AF5C-F634DDC7287DQ27349010-62980F09-FD1C-4849-9F49-053BCD95018CQ28082016-5F157D2D-324E-473A-B1BE-CCA117A0040AQ28388187-9DAB1867-6F1B-47CF-BA42-4E0D21A3A004Q30434041-A61BFEE5-CB3A-48D7-912D-36FB9454AD77Q35046585-E641A9DF-2004-47C7-AD1F-B496A908FF8FQ35778166-E3545BBB-A73D-4849-A404-3AAEF9BFA60CQ35949322-B1C3556A-AD38-4DCF-B6A9-C53B128F0ADBQ36307467-F84372B8-4674-42F8-9F4F-A01894AEF050Q36840729-E0D26F77-139C-4E8D-BF3B-9B24A6237AA1Q37416147-DDB794E0-ADCD-40FA-9A1F-CEAB4A89CB35Q37554396-CFF0CD2B-B1CB-4FD9-9DEE-F14A28401A68Q37766235-94D05754-5C72-4810-B235-538263C7247CQ37818329-6E15330B-94F9-443B-A744-660888E99624Q37880893-5FF03C37-E471-4440-830D-B60F81FF6493Q37946305-87FB1B48-57CF-451C-BD8E-E66C8523DD9CQ38055713-865FCBC4-065B-4110-8069-9C0B42825D0DQ38124859-F8B8561A-8314-4994-8CFA-6EAD75B3EA7CQ38254509-152C5051-E703-4E63-BC9D-DE7F69B1C0E2Q38702403-A5978613-09BF-4841-A595-6D84C9913F18Q40497617-4188630B-5EF1-411F-8C64-0E3127931F62Q40929566-50742AF4-DCF0-49F4-8AAB-3FD05215FF34Q41501993-6FBB6D0D-3A0F-4286-BEF1-B59BE4708BC7Q42011994-CFE9EECA-38FA-4F94-9D5F-D26355033235Q42743030-78661354-22FC-478C-A031-C5C09005978EQ43083731-487F2ED8-1B5D-4295-96F0-B48F850E22D8Q43101316-62374F9C-2284-40A1-A29F-2D092F3ADCD5Q43210325-A5E2D538-58D9-4ABD-BB63-BEF0ED4DA172Q43251444-5289B502-E95D-47C8-8CDF-FD88A34B0EFAQ46555341-B6C5D439-57F8-4BA2-917A-EC4BA3F59895Q46990286-3860A368-CA38-40E0-9561-40BE4A2A8F36Q47613313-24964B07-95AD-4E06-A99A-8AEA9AA4A385Q47927622-723D634E-CE97-4E97-923B-E93C0F57F83DQ48167102-128620F7-5F15-4397-9DB9-AF6D90BDE053Q48340466-8C268893-FF40-476F-A7C7-5095AAF532CCQ48457161-A3D25996-4793-4351-AEA5-F5C069FB1459Q48457386-88D2A721-1F92-422C-BFA0-5CA938BE7B87
P2860
Nasal drug administration: potential for targeted central nervous system delivery.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Nasal drug administration: potential for targeted central nervous system delivery.
@ast
Nasal drug administration: potential for targeted central nervous system delivery.
@en
type
label
Nasal drug administration: potential for targeted central nervous system delivery.
@ast
Nasal drug administration: potential for targeted central nervous system delivery.
@en
prefLabel
Nasal drug administration: potential for targeted central nervous system delivery.
@ast
Nasal drug administration: potential for targeted central nervous system delivery.
@en
P356
P1476
Nasal drug administration: potential for targeted central nervous system delivery.
@en
P2093
Candace L Graff
Gary M Pollack
P304
P356
10.1002/JPS.20318
P407
P577
2005-06-01T00:00:00Z